<?xml version="1.0" encoding="UTF-8"?>
<mx:collection xmlns:mx="http://www.loc.gov/MARC21/slim">
    <mx:record id="10945">
        <mx:leader/>
        <datafield tag="022" ind1="" ind2="">
            <subfield code="a">1938-2014</subfield>
        </datafield>
        <datafield tag="100" ind1="" ind2="">
            <subfield code="a">Melis Karaca</subfield>
        </datafield>
        
        <datafield tag="210" ind1="" ind2="">
            <subfield code="a">islets</subfield>
        </datafield>
        
        <datafield tag="245" ind1="" ind2="">
            <subfield code="a">In vivo functional heterogeneity among β-cells</subfield> 
        </datafield>
        
        <datafield tag="260" ind1="3" ind2="">
            <subfield code="b">Landes Bioscience</subfield>
            <subfield code="c">2010-03-01</subfield>
        </datafield>
        
        <datafield tag="302" ind1="" ind2="">
            <subfield code="a">124 - 126</subfield>
        </datafield>
        
        <datafield tag="440" ind1="" ind2="">
            
            <subfield code="a">Islets</subfield>
            <subfield code="v">2-2</subfield>
        </datafield>
        <datafield tag="449" ind1="" ind2="">
            <subfield code="o">Landes Bioscience</subfield>
        </datafield>
        <datafield tag="520" ind1="3" ind2="">
            <subfield code="a">The concept of functional heterogeneity among β-cells proposes that each cell differs in its sensitivity to glucose and is recruited in a glucose-dependent manner into both biosynthetic and secretory active states in order to adapt insulin secretion to the metabolic environment. Therefore, characterization of β-cell populations with different metabolic sensitivities would lead to the development of new therapeutic strategies. Based on heterogeneous surface PSA-NCAM expression on β-cells, we have recently characterized two groups of cells, namely β&lt;sup&gt;high&lt;/sup&gt; and β&lt;sup&gt;low&lt;/sup&gt;-cells, in rat. Differences in insulin secretory capacity and in gene expression profiles suggest that βlow-cells are immature and/or non-functional cells in contrast to highly glucose responsive fully functional β&lt;sup&gt;high&lt;/sup&gt;-cells. Moreover, the relative distribution of β&lt;sup&gt;high&lt;/sup&gt; and β&lt;sup&gt;low&lt;/sup&gt;-cells correlated with physiological and pathological states regarding the functional β-cell mass. Here we summarize our main results on β&lt;sup&gt;high&lt;/sup&gt; and β&lt;sup&gt;low&lt;/sup&gt;-cell populations and discuss some of the open remaining questions.</subfield>
        </datafield>
        <datafield tag="856" ind1="4" ind2="">
            
            <subfield code="u">http://dx.doi.org/10.4161/isl.2.2.10945</subfield>
            <subfield code="u">http://www.landesbioscience.com/journals/islets/article/10945/</subfield>
        </datafield>
 
        <datafield tag="949" ind1="" ind2="">
            <subfield code="t">article</subfield>
            <subfield code="n">Article Addendum</subfield>
        </datafield>
    </mx:record>

</mx:collection>